论文部分内容阅读
目的:观察孟鲁司特钠联合吸入糖皮质激素对治疗儿童哮喘临床效果。方法:选取我院收治的40例支气管哮喘患儿,将其随机分为观察组和对照组,每组均为20例,两组患者都吸入布地奈德,在此基础上,观察组加服孟鲁司特,对照组不加服孟鲁司特,其他治疗方法与观察组一样,两组在治疗期间如有哮喘急性发作,均给其服用糖皮质激素或静滴,疗程为6周。结果:观察组的治疗效果明显优于对照组,治疗后3个月对其进行复检,观察组的复发率要比对照组少。结论:孟鲁司特钠联合吸入糖皮质激素治疗儿童哮喘的治疗效果较为显著,值得临床推广。
Objective: To observe the clinical effect of montelukast combined with inhaled corticosteroids in the treatment of childhood asthma. Methods: Forty children with bronchial asthma admitted to our hospital were randomly divided into observation group and control group, with 20 cases in each group. Both groups inhaled budesonide. On the basis of this, the observation group plus Montelukast, the control group did not take montelukast, the other treatment methods and observation group, both groups in the treatment of acute exacerbation of asthma, were given glucocorticoid or intravenous infusion, the course of treatment for 6 weeks. Results: The treatment group was significantly better than the control group, 3 months after treatment, re-examination of the observation group, the recurrence rate was less than the control group. Conclusion: Montelukast combined with inhaled corticosteroids in the treatment of childhood asthma is more effective and worthy of clinical promotion.